Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation

Clinical trial NCT04838704 · COMPLETED

Trial details

NCT number: NCT04838704
Sponsor: Zhejiang University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Graft Versus Host Disease

Start date: 2021-04-01
Primary completion: 2024-12-01
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.